The cardiovascular adverse effects that may occur during treatment with the different categories of psychotropic drugs and the differences between single drugs within each category are reviewed. The main adverse reactions reported during psychotropic drug treatments are, in order of prevalence, (1) arrhythmias, since antidepressants and neuroleptics affect several ion channels involved in the control of cardiac action potentials and thus exert a proarrhythmic activity; (2) changes in blood pressure; (3) impairment of ventricular function; and (4) thromboembolism. Benign arrhythmias and orthostatic hypotension are the most common and most manageable adverse effects. Arrhythmias, including torsades de pointes, and impairment of ventricular function may lead to sudden death whoseodds ratio for the antipsychotics ranges between 1.72 for quetiapine and 3.67 for clozapine. The risk of cardiovascular adverse effects is higher for the typical antipsychotics than for the atypical. Among the latter, clozapine prescription requires particular attention. Tricyclic antidepressants and lithium are frequently accompanied by dysrhythmias, including QT interval prolongation, but sudden death is a rare event. A marginal risk of myocardial infarction during antidepressant therapy exists, but the risk of cardiovascular adverse effects with non-tricyclic antidepressants is remarkably low and practically nonexistent for the mood modifiers, except lithium and anxiolytics.

Cardiovascular Adverse Effects of Psychotropic Drugs / Pugliese, Anna Maria; Coppi, Elisabetta; Cherchi, Federica; Pepeu, Giancarlo. - ELETTRONICO. - (2019), pp. 1-15. [10.1007/978-3-319-90305-7_45-1]

Cardiovascular Adverse Effects of Psychotropic Drugs

Pugliese, Anna Maria;Coppi, Elisabetta;Cherchi, Federica;Pepeu, Giancarlo
2019

Abstract

The cardiovascular adverse effects that may occur during treatment with the different categories of psychotropic drugs and the differences between single drugs within each category are reviewed. The main adverse reactions reported during psychotropic drug treatments are, in order of prevalence, (1) arrhythmias, since antidepressants and neuroleptics affect several ion channels involved in the control of cardiac action potentials and thus exert a proarrhythmic activity; (2) changes in blood pressure; (3) impairment of ventricular function; and (4) thromboembolism. Benign arrhythmias and orthostatic hypotension are the most common and most manageable adverse effects. Arrhythmias, including torsades de pointes, and impairment of ventricular function may lead to sudden death whoseodds ratio for the antipsychotics ranges between 1.72 for quetiapine and 3.67 for clozapine. The risk of cardiovascular adverse effects is higher for the typical antipsychotics than for the atypical. Among the latter, clozapine prescription requires particular attention. Tricyclic antidepressants and lithium are frequently accompanied by dysrhythmias, including QT interval prolongation, but sudden death is a rare event. A marginal risk of myocardial infarction during antidepressant therapy exists, but the risk of cardiovascular adverse effects with non-tricyclic antidepressants is remarkably low and practically nonexistent for the mood modifiers, except lithium and anxiolytics.
2019
978-3-319-90305-7
978-3-319-90305-7
Brain and Heart Dynamics
1
15
Pugliese, Anna Maria; Coppi, Elisabetta; Cherchi, Federica; Pepeu, Giancarlo
File in questo prodotto:
File Dimensione Formato  
Pugliese et al., 2019 libro.pdf

Accesso chiuso

Tipologia: Pdf editoriale (Version of record)
Licenza: DRM non definito
Dimensione 283.56 kB
Formato Adobe PDF
283.56 kB Adobe PDF   Richiedi una copia

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1175404
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact